MarketBeat is an American financial media company headquartered in Sioux Falls, South Dakota, founded in 2011 by Matthew Paulson as Analyst Ratings Network before rebranding in 2015. The company operates an online platform that delivers real-time financial data, market analysis, and news, aiming to empower individual investors with tools to make informed trading decisions.
Amazon's pullback is about capex fears, not business deterioration, and with AWS accelerating and analysts staying bullish, this could be a great entry point.
Bitcoin has fallen below $60,000 amid record ETF outflows and institutional selling, making MSTR, BLSH, and BITO the stocks most exposed to a crypto downturn.
Alnylam Pharmaceuticals (NASDAQ:ALNY) executives outlined the company’s 2030 financial targets, TTR franchise strategy and near-term pipeline priorities during a Goldman Sachs event hosted by analyst Salveen Richter.
Jeff Poulton, Alnylam’s chief financial officer, said the company’s “Alnylam 2030”
Uranium Energy (NYSEAMERICAN:UEC) said on its latest earnings call that it advanced several parts of its U.S. uranium production platform during the quarter, including the start of production at Burke Hollow in South Texas and continued development at Christensen Ranch in Wyoming.
Founder and Chief
Academy Sports and Outdoors (NASDAQ:ASO) reported a return to comparable sales growth in its fiscal first quarter, with management pointing to gains across all major merchandise divisions, strong e-commerce growth and momentum from newer stores.
The sporting goods retailer said first-quarter net sa
Oil-Dri Corporation Of America (NYSE:ODC) reported stronger fiscal third-quarter sales and operating income, while management cautioned that higher costs and an ongoing capital investment cycle are continuing to pressure margins.
On the company’s Q3 fiscal 2026 earnings webcast, Chief Financial Off
Intel, IBM, and other legacy tech giants are doubling down on quantum computing, putting pure-play firms like D-Wave and Rigetti in a difficult position.
United Natural Foods (NYSE:UNFI) reported stronger third-quarter fiscal 2026 profitability and cash flow despite lower sales, as management said network optimization, productivity initiatives and supply chain investments continued to reshape the business.
On the company’s earnings call, CEO Sandy D
Amgen (NASDAQ:AMGN) executives said the company’s first-quarter performance supports its view that 2026 can serve as a “springboard year,” with growth products helping offset increased competition for the denosumab franchise and other losses of exclusivity.
Speaking at a Goldman Sachs event, Peter
Lands' End (NASDAQ:LE) reported lower first-quarter revenue as a distribution center systems rollout delayed shipments, but executives said underlying demand improved and described the recently completed joint venture with WHP Global as a major strategic reset for the apparel retailer.
Chief Execut
SailPoint (NASDAQ:SAIL) reported a stronger-than-expected start to fiscal 2027, with management pointing to continued SaaS migration activity, larger customer commitments and growing demand for identity security tied to artificial intelligence agents and other non-human identities.
On the company’s
Titan Machinery (NASDAQ:TITN) reported fiscal first-quarter results that management said were slightly ahead of expectations, helped by earlier-than-anticipated equipment margin improvement, but the company reaffirmed its full-year outlook as demand remains pressured across key customer groups.
Pre
EHang (NASDAQ:EH) said it remains focused on moving from aircraft certification to commercial operations after reporting first-quarter 2026 revenue that was roughly flat year over year but sharply lower than the prior quarter due to delivery timing and seasonal factors.
Founder, Chairman and Chief
Molten Ventures (LON:GROW) said portfolio fair value growth accelerated during the year, while management pointed to defense, space, artificial intelligence and European technology sovereignty as major structural themes shaping its investment strategy.
Chief Executive Ben Wilkinson told investors t
Temu owner PDD keeps sinking. The company is prioritizing long-term competitiveness over short-term results, creating potential for an extended recovery.
Frontline, Euroseas, and Nordic American Tankers raised dividends in 2026, with Frontline boosting its payout 50% after reporting its highest quarterly profit since 2004.
Pinterest, Southwest Airlines, and United Therapeutics each executed significant share repurchases in Q1 2026, reducing their outstanding share counts by 16%, 5%, and 3.2%, respectively.
TH International (NASDAQ:THCH), the operator of Tims China, reported weaker first-quarter 2026 sales as management continued to close underperforming stores, reduce discount-driven promotions and shift resources toward franchising and profitability.
On the company’s earnings call, CEO Director Yong
Annexon (NASDAQ:ANNX) executives used a Goldman Sachs Healthcare Conference session to outline the company’s upcoming clinical and regulatory catalysts, led by pivotal Phase III data expected in the fourth quarter for vonaprument in geographic atrophy, a form of advanced dry age-related macular dege
J. M. Smucker (NYSE:SJM) reported stronger fourth-quarter results and outlined expectations for fiscal 2027, with management emphasizing growth in key brands, improving profitability and continued debt reduction.
In prepared remarks, Mark Smucker, Chief Executive Officer, President and Chair of the
Caribou Biosciences (NASDAQ:CRBU) Chief Executive Officer Rachel Haurwitz said the company is advancing two CRISPR-enabled, off-the-shelf CAR T cell therapy programs, with its lymphoma candidate vispa-cel now “pivotal-ready” and its multiple myeloma program CB-011 continuing in Phase 1 development.
Oxford Instruments (LON:OXIG) said it delivered a stronger second half after a difficult start to the year, as improving demand from commercial semiconductor customers helped offset weaker academic markets and geopolitical uncertainty.
Chief Executive Richard Tyson told investors the company was “r
Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Yuval Cohen outlined the company’s near-term clinical readout schedule and development plans for its two lead drug candidates during a Jefferies fireside chat hosted by biotech analyst Amin Makarem.
Cohen said the Norwood, Massachusetts-based dru
Hemab Therapeutics (NASDAQ:COAG) Chief Executive Officer Benny Sorensen outlined the company’s development plans following its recent initial public offering during a fireside chat with Jefferies biotech analyst Maury Raycroft.
Sorensen said Hemab is pursuing a strategy to build “a multiple product
Zepp Health (NYSE:ZEPP) reported a stronger start to 2026, with management pointing to new Amazfit product launches, a higher-end product mix and expanding positioning in hybrid training as the main drivers of first-quarter growth.
On the company’s earnings call, Founder and Chief Executive Officer
CareDx (NASDAQ:CDNA) executives outlined the company’s strategy to focus on precision diagnostics, expand into minimal residual disease testing and improve profitability during a Goldman Sachs-hosted discussion.
Chief Executive Officer John Hanna said CareDx has reshaped its portfolio around areas
Bioventus (NASDAQ:BVS) executives outlined the company’s portfolio strategy, growth priorities and capital allocation plans during a Goldman Sachs event hosted by Jenny Rabinowitz, an analyst covering U.S. medtech and healthcare IT.
Mark Singleton, Bioventus’ senior vice president and chief financi
Vail Resorts (NYSE:MTN) said historically poor weather across the Western United States continued to weigh on fiscal third-quarter results, pressuring visitation and revenue at its mountain resorts while management emphasized that its advance commitment pass model and cost controls helped cushion th
Gloo (NASDAQ:GLOO) reported fiscal first-quarter revenue and adjusted EBITDA ahead of its own guidance and Wall Street consensus, as executives pointed to momentum from large strategic customers, recent acquisitions and growing demand for AI-enabled technology and marketing tools across faith-based
Mama's Creations (NASDAQ:MAMA) reported sharply higher first-quarter fiscal 2027 results, with management pointing to new retail placements, the Crown I acquisition and broader customer growth as the main drivers, even as gross margins were pressured by launch-related costs.
Chairman and CEO Adam L
Mission Produce (NASDAQ:AVO) said its fiscal second quarter was pressured by an unusually high-supply avocado market, particularly from Mexico, which drove prices to multi-year lows and compressed margins despite higher avocado volumes.
President and Chief Executive Officer John Pawlowski, who form
Motorcar Parts of America (NASDAQ:MPAA) reported stronger fiscal fourth-quarter and full-year results, with management pointing to sales momentum, new business commitments and improving profitability as key drivers heading into fiscal 2027.
Chairman, President and Chief Executive Officer Selwyn Jof
Amprius Technology is on track to set a new all-time high later this year after it reports Q2 results and guidance. Short interest suggests a squeeze is possible.
Broadcom, Palo Alto Networks, and Planet Labs each reported strong results and offer potential upside as investors position for the second half of 2025.
A weaker dollar means international revenue can have a bigger impact, and these companies might be positioned to take advantage of an otherwise tough situation.
Graham (NYSE:GHM) reported record fiscal 2026 revenue, orders and backlog, with management pointing to strong demand in defense, improving momentum in space and contributions from recent acquisitions as the company enters fiscal 2027.
On the company’s fiscal fourth-quarter earnings call, President
Assembly Biosciences (NASDAQ:ASMB) outlined its antiviral and liver disease development strategy during a fireside chat at the 47th Annual Goldman Sachs Healthcare Conference, highlighting upcoming decisions tied to its herpes simplex virus type 2 program, expansion of its hepatitis delta candidate
"Quality" stocks may be better able to withstand market turbulence thanks to stable earnings, strong balance sheets, and more; these ETFs aim to find them.
Optical Cable (NASDAQ:OCC) reported sharply higher fiscal second-quarter sales and profit, with management citing strength in enterprise, data center and severe-duty markets, as well as improved manufacturing leverage.
On the company’s fiscal 2026 second-quarter earnings call, President and Chief E
Marc Lichtenfeld highlights HAL, CVX, and HASI as energy stocks positioned to benefit from AI-driven electricity demand growth forecast at 3.5% annually through 2030.
Duluth (NASDAQ:DLTH) reported a narrower first-quarter loss and higher gross margins as management said its ongoing effort to reduce promotions, rationalize inventory and cut costs continued to reshape the apparel retailer’s financial profile.
President and Chief Executive Officer Stephanie Puglies
FuelCell Energy (NASDAQ:FCEL) reported a wider second-quarter loss for fiscal 2026 as a non-cash impairment tied to its Groton Navy project weighed on results, while management emphasized a sharply expanding sales pipeline tied largely to data center and artificial intelligence-related power demand.
Gamehaus (NASDAQ:GMHS) reported third-quarter fiscal 2026 revenue above its prior guidance range while management emphasized improving profitability, tighter marketing discipline and growing use of direct-to-consumer payments and artificial intelligence across the business.
On the company’s earning
VinFast Auto (NASDAQ:VFS) reported sharply higher first-quarter 2026 vehicle deliveries and revenue, while management said gross margin was pressured by accounting impacts tied to an expanded free-charging program and other adjustments.
On the company’s earnings call, Chairman Pham Nhat Quan Anh sa
Berkshire Hathaway just turned over a rock that many would not think to look under. See the status of its latest portfolio addition, retail giant Macy's.
Campbell's (NASDAQ:CPB) reported lower third-quarter fiscal 2026 results as weaker volumes, inflation and supply chain costs weighed on sales and profitability, while management reaffirmed its full-year outlook and said it is continuing to invest behind key brands.
President and CEO Mick Beekhuizen
Compass Therapeutics (NASDAQ:CMPX) Chief Executive Officer Tom Schuetz said the company is preparing for a key U.S. Food and Drug Administration meeting on tovecimig, its DLL4/VEGF bispecific antibody, after a randomized study in advanced biliary tract cancer met its primary endpoint and a key secon
AstroNova (NASDAQ:ALOT) reported higher fiscal first-quarter revenue and improved profitability, driven primarily by strength in its Aerospace segment, as management said the company is benefiting from commercial aircraft demand, growing orders and internal cost controls.
On the company’s fiscal 20
Basf (ETR:BAS) executives said the company’s new Zhanjiang Verbund site in Guangdong province has started operations successfully, positioning the German chemicals group for further growth in China while adding a major new production platform built around digitalization, feedstock flexibility and re
CME Group (NASDAQ:CME) Chairman and CEO Terry Duffy sharply criticized the Commodity Futures Trading Commission’s approval of a Bitcoin perpetual futures contract for Kalshi, saying the product does not fit his view of a futures contract and raises risks for retail investors.
Speaking at an investo
Chime Financial (NASDAQ:CHYM) founder and CEO Chris Britt outlined the digital banking company’s growth strategy, product roadmap and margin targets during a presentation at the William Blair conference, emphasizing Chime’s focus on primary checking relationships and mainstream U.S. consumers.
Brit
CG Oncology (NASDAQ:CGON) is focused on advancing cretostimogene, an oncolytic immunotherapy for non-muscle invasive bladder cancer, Chief Executive Officer Arthur Kuan said during a discussion at the Jefferies Global Healthcare Conference in New York.
Kuan said the company believes the therapy cou
Certara (NASDAQ:CERT) executives outlined the company’s strategic realignment, artificial intelligence initiatives and cost priorities during a discussion at Jefferies’ 2026 Global Healthcare Conference, with newly appointed Chief Executive Officer Jon Resnick saying the company is focused on creati
MetLife, Globe Life, and Unum Group are hitting 52-week highs as P&C premiums decline, rewarding insurers with life, group benefits, and health exposure.
Celsius (NASDAQ:CELH) executives said the company is working through a major portfolio transition as it integrates Alani and Rockstar into its platform while repositioning the core Celsius brand for renewed growth.
Speaking at an investor conference, Chairman and CEO John Fieldly described the comp
Market rotation into robotics, crypto infrastructure, AI data centers, and precious metals is creating opportunities in speculative stocks under $20, including SERV, BTBT, and CDE.
